HBV infection and hepatocellular carcinoma

Area of Science:

• Hepatology
• Oncology
• Virology

Background:

• Hepatitis B virus (HBV) is a primary driver of hepatocellular carcinoma (HCC), contributing to hundreds of thousands of annual deaths worldwide.
• Chronic HBV infection accounts for a substantial proportion of HCC cases, particularly in Asia and Africa (60%), and a significant percentage in Europe, Japan, and the United States (at least 20%).

Purpose of the Study:

• To elucidate the pathogenic role of HBV in the development of HCC.
• To discuss the associated risks of HCC in the context of chronic HBV infection.
• To review current diagnostic and treatment strategies for HBV-related HCC.

Main Methods:

• Literature review and synthesis of existing data on HBV pathogenesis and HCC.
• Analysis of epidemiological data linking HBV infection to HCC incidence and mortality.
• Discussion of clinical management guidelines for chronic hepatitis B and HCC.

Main Results:

• HBV infection is a major etiological factor for HCC, leading to significant global morbidity and mortality.
• HCC development is strongly associated with chronic hepatitis or cirrhosis stemming from HBV infection.
• Early diagnosis is identified as the most practical strategy for improving patient prognosis.

Conclusions:

• HBV plays a critical role in the pathogenesis of HCC.
• Management of chronic HBV infection is essential for HCC prevention.
• Timely diagnosis and appropriate treatment are key to improving survival rates for HCC patients.